In this review, new therapeutic targets for lupus nephritis, potential pathologies and promising therapeutic approaches to the JAK-STAT and TIM-1-TIM-4 signaling pathways from basic science to clinical practice are presented. The gene discussed is TIMD4; the disease is lupus nephritis.